Search Results - "van Nooten, Floortje"

Refine Results
  1. 1

    Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-Analysis by van Nooten, Floortje, MSc, Treur, Maarten, MSc, Pantiri, Krystallia, MSc, Stoker, Malcolm, PhD, Charokopou, Mata, MSc

    Published in Clinical therapeutics (01-04-2017)
    “…Abstract Purpose A network meta-analysis (NMA) was performed, aiming to assess the relative efficacy and tolerability of the capsaicin 179-mg (8% weight for…”
    Get full text
    Journal Article
  2. 2

    Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature by Alleman, Cathelijne J.M, Westerhout, Kirsten Y, Hensen, Marja, Chambers, Colette, Stoker, Malcolm, Long, Stephen, van Nooten, Floortje E

    Published in Diabetes research and clinical practice (01-08-2015)
    “…Highlights • A formal review was conducted for painful diabetic peripheral neuropathy (PDPN). • European PDPN prevalence ranges from 6% to 34% in diabetic…”
    Get full text
    Journal Article
  3. 3

    Development and content validation of a patient-reported endometriosis pain daily diary by van Nooten, Floortje E, Cline, Jennifer, Elash, Celeste A, Paty, Jean, Reaney, Matthew

    Published in Health and quality of life outcomes (04-01-2018)
    “…Endometriosis is a common gynecological disorder that causes inflammation and pelvic pain. Endometriosis-related pain is best captured with patient-reported…”
    Get full text
    Journal Article
  4. 4

    Development of the neurotrophic keratopathy questionnaire: qualitative research by Murray, Lindsey T., McCormack, Julie, Grobeiu, Ioana, Wiklund, Ingela, Kimel, Miriam, Van Nooten, Floortje

    Published in Journal of patient-reported outcomes (04-05-2020)
    “…Background Neurotrophic keratopathy/keratitis (NK) is a rare disease of the cornea that can lead to anatomical loss of the eye. Little is known about the NK…”
    Get full text
    Journal Article
  5. 5

    Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia by Eriksson, Daniel, Goldsmith, David, Teitsson, Siguroli, Jackson, James, van Nooten, Floortje

    Published in BMC nephrology (26-07-2016)
    “…Deteriorating renal function in chronic kidney disease (CKD) patients is commonly associated with reduced haemoglobin levels, adding to the already…”
    Get full text
    Journal Article
  6. 6

    The influence of subjective expectations about length and quality of life on time trade-off answers by Nooten, Floortje van, Brouwer, Werner

    Published in Health economics (01-08-2004)
    “…When answering TTO questions respondents sometimes have to imagine being in a certain health state during their remaining lifespan, often based on objective…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease by Finkelstein, Fredric O, van Nooten, Floortje, Wiklund, Ingela, Trundell, Dylan, Cella, David

    Published in Health and quality of life outcomes (31-05-2018)
    “…Anemia is a common and debilitating manifestation of chronic kidney disease (CKD). Data from two clinical trials in patients with anemia of CKD were used to…”
    Get full text
    Journal Article
  9. 9
  10. 10

    An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D by Feng, Yan, Herdman, Mike, van Nooten, Floortje, Cleeland, Charles, Parkin, David, Ikeda, Shunya, Igarashi, Ataru, Devlin, Nancy J.

    Published in Quality of life research (01-08-2017)
    “…Purpose To investigate the systematic differences in the self-reporting and valuation of overall health and, in particular, pain/discomfort between three…”
    Get full text
    Journal Article
  11. 11

    A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease by RUTTEN-VAN MÖLKEN, Maureen P. M. H, VAN NOOTEN, Floortje E, LINDEMANN, Marion, CAESER, Manfred, CALVERLEY, Peter M. A

    Published in PharmacoEconomics (01-01-2007)
    “…Roflumilast is an oral, once-daily phosphodiesterase IV (PDE4) inhibitor under investigation for chronic obstructive pulmonary disease (COPD). This study…”
    Get full text
    Journal Article
  12. 12

    Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States by Lo, Siu Hing, Lloyd, Andrew, Elkhalifa, Shuayb, Sisic, Zlatko, van Nooten, Floortje E.

    Published in PharmacoEconomics - open (01-03-2022)
    “…Background Hereditary angioedema (HAE) is an inherited chronic rare disease characterised by recurrent swelling attacks that are associated with significant…”
    Get full text
    Journal Article
  13. 13

    Health-Related Quality of Life of Patients with Acute Myeloid Leukemia: A Systematic Literature Review by Korol, Ellen E., Wang, Sisi, Johnston, Karissa, Ravandi-Kashani, Farhad, Levis, Mark, van Nooten, Floortje

    Published in Oncology and therapy (01-06-2017)
    “…Introduction Patients with acute myeloid leukemia (AML), especially those with relapsed or refractory AML, have poor clinical prognosis and outcomes…”
    Get full text
    Journal Article
  14. 14

    Neuropathic pain: A patient‐centred approach to measuring outcomes by Hwang, Steve, van Nooten, Floortje, Wells, Ted, Ryan, Aisling, Crawford, Bruce, Evans, Christopher, English, Marci

    “…Background Neuropathic pain (NP) is a complex, chronic pain state initiated by a primary lesion or dysfunction of the nervous system and presents as a variety…”
    Get full text
    Journal Article
  15. 15

    Health economics and outcomes research within drug development Challenges and opportunities for reimbursement and market access within biopharma research by NOOTEN, Floortje Van, HOLMSTROM, Stefan, GREEN, Julia, WIKLUND, Ingela, ODEYEMI, Isaac A. O, WILCOX, Teresa K

    Published in Drug discovery today (01-06-2012)
    “…Healthcare decision makers who determine funding for new medical technologies depend on manufacturers to provide evidence of the technology's efficacy, safety…”
    Get full text
    Journal Article
  16. 16

    The Patient Perspective on Living with Acute Myeloid Leukemia by Tomaszewski, Erin L., Fickley, Catherine E., Maddux, LeAnne, Krupnick, Robert, Bahceci, Erkut, Paty, Jean, van Nooten, Floortje

    Published in Oncology and therapy (01-12-2016)
    “…Introduction Acute myeloid leukemia (AML) imposes significant burden on patients, their families, and the healthcare system. Published literature has reported…”
    Get full text
    Journal Article
  17. 17

    Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literature by van Nooten, Floortje E, Green, Julia, Brown, Ruth, Finkelstein, Fredric O, Wish, Jay

    Published in Journal of medical economics (14-07-2010)
    “…To assess the health-related quality of life (HRQL) and economic burden of chronic kidney disease (CKD) related anemia in non-dialysis patients in the United…”
    Get more information
    Journal Article
  18. 18

    Evaluating the Measurement Properties of the Self-Assessment of Treatment Version II, Follow-Up Version, in Patients with Painful Diabetic Peripheral Neuropathy by van Nooten, Floortje, Trundell, Dylan, Staniewska, Dorota, Chen, Jun, Davies, Evan W., Revicki, Dennis A.

    Published in Pain Research and Treatment (01-01-2017)
    “…Background. The Self-Assessment of Treatment version II (SAT II) measures treatment-related improvements in pain and impacts and impressions of treatment in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Measurement properties of the Short Form-36 in patients with anemia associated with chronic kidney disease by Finkelstein, Fredric O, van Nooten, Floortje, Wiklund, Ingela, Trundell, Dylan, Cella, David

    Published in Health and quality of life outcomes (31-05-2018)
    “…Anemia is a common and debilitating manifestation of chronic kidney disease (CKD). Data from two clinical trials in patients with anemia of CKD were used to…”
    Get full text
    Journal Article